Benjamin Scherlag to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Benjamin Scherlag has written about Anti-Arrhythmia Agents.
Connection Strength
2.030
-
When nerves go awry: The multiple ways to treat atrial fibrillation. Heart Rhythm. 2016 11; 13(11):2118.
Score: 0.511
-
Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies. Trends Cardiovasc Med. 2021 02; 31(2):127-132.
Score: 0.163
-
Slow antegrade excitation and delayed retrograde activation through an "inexcitable zone": A basis for arrhythmia formation in infarcted myocardium ex vivo. J Cardiovasc Electrophysiol. 2017 Oct; 28(10):1213-1222.
Score: 0.136
-
Acetylcholine-Atropine Interactions: Paradoxical Effects on Atrial Fibrillation Inducibility. J Cardiovasc Pharmacol. 2017 Jun; 69(6):369-373.
Score: 0.136
-
Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation. J Cardiovasc Electrophysiol. 2012 Jul; 23(7):771-7.
Score: 0.095
-
Pharmacological prevention and termination of focal atrial fibrillation. Europace. 2012 Mar; 14(3):426-30.
Score: 0.092
-
Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications. J Cardiovasc Transl Res. 2011 Feb; 4(1):35-41.
Score: 0.086
-
Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium. J Cardiovasc Pharmacol. 2007 Sep; 50(3):304-13.
Score: 0.069
-
Treatment of arrhythmias by blocking slow current. Ann Intern Med. 1980 Dec; 93(6):919-21.
Score: 0.043
-
The acute and subchronic toxicity of BRB-I-28, a novel class Ib antiarrhythmic agent, in CD-1 mice. Food Chem Toxicol. 2000 Sep; 38(9):817-23.
Score: 0.043
-
Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes. Life Sci. 2000 Mar; 66(17):PL 253-8.
Score: 0.041
-
Preliminary acute and subchronic toxicity studies of GLG-V-13, a novel class III antiarrhythmic agent, in mice. Arzneimittelforschung. 2000 Jan; 50(1):31-8.
Score: 0.041
-
Facilitation of epinephrine-induced afterdepolarizations by class III antiarrhythmic drugs. J Electrocardiol. 1997 Jul; 30(3):217-24.
Score: 0.034
-
Early afterdepolarizations produced by d,l-sotalol and clofilium. J Cardiovasc Electrophysiol. 1997 Jun; 8(6):667-78.
Score: 0.034
-
Class III electrophysiologic actions of imidazole-substituted diheterabicyclononanes in canine myocardium. J Pharmacol Exp Ther. 1997 Apr; 281(1):155-62.
Score: 0.034
-
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart. J Cardiovasc Pharmacol. 1996 Aug; 28(2):182-91.
Score: 0.032
-
Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperchlorate. J Med Chem. 1996 Jun 21; 39(13):2559-70.
Score: 0.032
-
Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate. Arzneimittelforschung. 1995 Jun; 45(6):670-5.
Score: 0.030
-
Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart. Acta Physiol Hung. 1995; 83(1):13-30.
Score: 0.029
-
The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate. Circulation. 1974 Sep; 50(3):507-14.
Score: 0.028
-
Effects of novel antiarrhythmic agents, BRB-I-28 and its derivatives, on the heart mitochondrial respiratory chain and sarcoplasmic reticulum Ca(2+)-ATPase. Res Commun Mol Pathol Pharmacol. 1994 Aug; 85(2):193-208.
Score: 0.028
-
Effects of disopyramide on electrophysiological and mechanical properties of the heart. J Pharm Sci. 1973 Dec; 62(12):1924-9.
Score: 0.027
-
Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium. J Cardiovasc Pharmacol. 1993 Apr; 21(4):637-46.
Score: 0.025
-
The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart. Acta Physiol Hung. 1993; 81(3):289-99.
Score: 0.025
-
High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urine. J Chromatogr. 1992 Dec 02; 583(2):274-9.
Score: 0.025
-
Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force. Res Commun Chem Pathol Pharmacol. 1992 Oct; 78(1):3-16.
Score: 0.025
-
Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium. J Pharmacol Exp Ther. 1992 Jul; 262(1):375-82.
Score: 0.024
-
The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogs. Proc West Pharmacol Soc. 1992; 35:87-91.
Score: 0.023
-
Electrophysiological actions of BRB-I-28 in canine myocardial tissues. J Pharmacol Exp Ther. 1991 Nov; 259(2):558-65.
Score: 0.023
-
An acute experimental model demonstrating 2 different forms of sustained atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2009 Aug; 2(4):384-92.
Score: 0.019
-
Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist. J Cardiovasc Electrophysiol. 2008 Aug; 19(8):861-8.
Score: 0.018
-
Synthesis, conformational analysis, and antiarrhythmic properties of 7-benzyl-3-thia-7-azabicyclo[3.3.1]nonan-9-one, 7-benzyl-3-thia-7-azabicyclo[3.3.1]nonane hydroperchlorate, and 7-benzyl-9-phenyl-3-thia-7-azabicyclo[3.3.1]nonan-9-ol hydroperchlorate and derivatives: single-crystal X-ray diffraction analysis and evidence for chair-chair and chair-boat conformers in the solid state. J Med Chem. 1984 Jun; 27(6):758-67.
Score: 0.014
-
Electrophysiologic basis for arrhythmias in ischemic heart disease. Am J Cardiol. 1984 Feb 27; 53(5):1B-7B.
Score: 0.014
-
Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation. Circulation. 1983 Nov; 68(5):906-16.
Score: 0.013
-
A technique for stable His-bundle recording and pacing: electrophysiological and hemodynamic correlates. Pacing Clin Electrophysiol. 1995 Oct; 18(10):1894-901.
Score: 0.008
-
The monophasic action potential in clinical cardiology. Clin Cardiol. 1991 Jun; 14(6):505-10.
Score: 0.006
-
Diphenylhydantoin prevention of arrhythmias in the digitalis-sensitized dog after direct-current cardioversion. Circulation. 1968 Mar; 37(3):424-8.
Score: 0.004
-
Effect of diphenylhydantoin sodium (dilantin) on myocardial A-V potassium difference. Am J Physiol. 1968 Apr; 214(4):880-4.
Score: 0.001